- Founder(s): Dr. Christian Schwarz and Philipp Bürling
- Established: 2017
- CEO(s): Dr. Christian Schwarz
- Employees: 6
- Financial Data: Privately funded
- Website: numaferm.com
NUMAFERM is a pioneer in the production of recombinant peptides. By lowering production costs significantly, they are going to make peptides more affordable and thus available to new markets.
The company has developed a biotechnology for the plannable and efficient production of peptides.
In regards to their location, Düsseldorf has a great startup ecosystem with many investors and potential customers from the chemical and pharmaceutical industry available.